Aptar Pharma chosen for the Innovation tour at Pharmapack Europe
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, will participate at the Innovation tour organized into the Pharmapack Europe conference, to be held on February 10 and 11, 2016, in Paris Porte de Versailles.
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, will participate at the Innovation tour organized into the Pharmapack Europe conference, to be held on February 10 and 11, 2016, in Paris Porte de Versailles.
Chris Baron, Associate Director Business Development at Aptar Pharma will present our latest innovation: DF30 Technology Platform with COCe, on February 11, at 11.25 am, on the Aptar Pharma booth #612.
This brand new DF30 Technology Platform metering valve incorporates a Cyclic-Olefin-Copolymer (COC) neck gasket to further enhance its performance. It is the result of continuous improvement to today's world leading DF30 technology platform.
DF30 Technology Platform with COCe : ultra-clean, robust and versatile
Aptar Pharma's DF30 metering valve technology platform has been the industry gold standard for more than 20 years and we are constantly striving to optimize our DF30 product offering.
COC is a well-known and characterized material used for injectable drug containers. COCe is a specific version of COC that has unique elastomeric properties while being ultraclean and inert.
The new version of DF30 Technology Platform that incorporates a neck gasket manufactured with COCe offers several key benefits:
- Step change improvement as a barrier to leakage
- Ultra low extractible level
- Compatibility across a wider range of drug formulations, including ethanol-containing formulations
- Suitable for all pMDI filling technologies
- Robust design for accurate and consistent performance
For more information on DF30 Technology Platform, please visit our booth #612 or our website:
Contacts:
Chris Baron, Associate Director Business Development, Aptar Pharma
chris.baron@aptar.com
About Aptar Pharma
Aptar Pharma is a part of the AptarGroup family of companies, along with Aptar
Beauty + Home and Aptar Food + Beverage.
AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage markets.
AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. To learn more, visit www.aptar.com/pharma.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
